Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

MedicalJane

OCTOBER 3, 2019

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. Dr. Eric Hollander, the Director of the Autism and Obsessive Compulsive Spectrum Program and Anxiety and Depression Program at Montefiore Hospital, is leading the clinical trial.

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

Project CBD

FEBRUARY 28, 2023

According to the FDA, “hemp” is defined as Cannabis sativa with a tetrahydrocannabinol (THC) concentration of 0.3% THC is the primary psychoactive compound in cannabis.) THC is considered “marijuana” or “cannabis.” Epilepsy Behav. Cannabis sativa with more than 0.3% Available at: www.fda.gov/media/131878/download.

CBD 144

CBD Seed-To-Sale Food Access 144

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Global Legal Cannabis Industry: Number of Clinical Trials, By Region. GW Pharmaceuticals, PLC.

Recreational 95

Recreational Hemp THC Legalization 95

Cannabis Law Report

NOVEMBER 1, 2021

These include tetrahydrocannabinol (THC), a psychoactive substance that gives users a “high”. “It It is difficult to get 100 per cent pure CBD extracts from cannabis, and there’s a chance the products will contain traces of THC or other substances,” the source said. The city vows zero tolerance to drugs.

Wellness and Beauty 52

Wellness and Beauty CBD Clinical Trials Pharmaceutical 52

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

The two active cannabinoids in marijuana are cannabidiol (CBD) and tetrahydrocannabinol (THC), the latter of which causes psychoactive effects while the former does not. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC. CBD for Anxiety. How to Use Cannabis for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Green Relief

MAY 13, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. CBD produces no intoxicating effects, no THC -like high, and its use does not lead to tolerance. Highlights: According to a U.S.

THC 64

THC CBD Cannabinoids Research and Development 64

MedicalJane

JUNE 29, 2018

The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. percent of tetrahydrocannabinol (THC), the cannabinoid responsible for producing “high” psychoactive effects when consumed. Prior to this week, the U.S.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

The Cannigma

JUNE 15, 2021

THC is by far the most abundant and popular molecule in marijuana. The two most well known and common cannabinoids are THC and CBD, and while they won’t alter the aroma and colors of cannabis, they do interact with numerous receptor systems in the human body and have a range of effects. CBD vs THC. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Knowing these can allow you or your healthcare provider to look up the metabolism of a pharmaceutical drug and determine if a CBD-drug interaction is possible.

CBD 98

CBD THC Conditions Medicine 98

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. Epidiolex has received FDA approval to treat Dravet Syndrome and Lennox-Gestaut Syndrome; two very rare forms of epilepsy that manifest in early childhood.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Cannabis Law Report

FEBRUARY 3, 2022

The presence of major key players, pharmaceutical and biotechnology industries worldwide, and their experimental approach drives the cannabis market growth. Based on the compound, the market is segmented into tetrahydrocannabinol (THC)-dominant, cannabidiol (CBD)-dominant, and balanced THC and CBD. Gw Pharmaceuticals plc.

Indica 52

Indica Oil Legalization Research and Development 52

Alchimia

FEBRUARY 1, 2022

CBD is one of the principal cannabinoids found in cannabis and, along with THC, one of its best-known compounds. The truth is that CBD has proven to have multiple properties that are useful both in the recreational field (since it modulates the adverse effects of THC) and in the medicinal field. Drowsiness. Mild fatigue.

CBD 52

CBD Epilepsy Research and Development Cannabinoids 52

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Previously a Schedule I substance, hemp was reclassified; hemp has extremely low levels of THC (less than 0.3%).

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

APRIL 10, 2019

Just over 80 prescriptions for medical cannabis (THC and CBD) have been written, according to Hancock. “We In relation to childhood epilepsy, the British Paediatric Neurology Association has issued interim clinical guidance. Here’s a quick precis care of Cannabis Wire Daily Newswire.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

CannaMD

AUGUST 8, 2020

But CBD’s stolen the spotlight, partially because of its good cop/bad cop relationship with another famous cannabinoid: T etrahydrocannabinol or THC. THC is responsible for marijuana’s psychoactive effects. If you feel “high,” THC’s usually to blame. CBD Scheduling Rule Change. CBD & Epidiolex.

CBD 99

CBD DEA Research and Development Hemp 99

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Knowing these can allow you or your healthcare provider to look up the metabolism of a pharmaceutical drug and determine if a CBD-drug interaction is possible.

CBD 52

CBD THC Conditions Medicine 52

SMPL

MAY 26, 2020

Mr. Laughter and Lawrence Ringo, an old-school hippie grower, were some of the first Americans to intentionally cultivate plants higher in CBD than in THC — the compound that does get you high. At the time of Samantha Miller’s summit in 2011, THC was the sole chemical “face” of the plant.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Puff Puff Post

DECEMBER 28, 2018

Influencing how information is processed and how nerve cells and synapses in the brain interact, the exact function related to autism is still not well understood, and no pharmaceuticals around yet can ‘fix’ autism. THC – the main molecule responsible for feeling high, stoned, or any effects associated with weed isn’t used for treatment.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

JANUARY 24, 2022

DUBLIN–(BUSINESS WIRE)–The “North America Legal Cannabis Market Size, Share & Trends Analysis Report by Sources (Marijuana, Hemp), by Derivatives (CBD, THC), by End Use (Medical, Recreational), and Segment Forecasts, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. from 2022 to 2028.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

The Cannigma

MAY 7, 2021

In Europe, Murphy explains, cannabis products are held to the same standards of accountability and repeatability as other pharmaceuticals. What do those more pharmaceutical standards mean for patients? MSO: Obviously, every country is different but within Europe and certain rainy islands close to it. SM: I think it’s stability.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Green Relief

MAY 12, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. CBD produces no intoxicating effects, no THC -like high, and its use does not lead to tolerance. Highlights: According to a U.S.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 17, 2019

Food and beverage makers are gearing up to sell CBD-containing products, when allowed by regulators, including Lagunitas Brewing, which has developed a cannabis-infused IPA and a THC-based sparkling water, and Ben & Jerry’s, which plans to offer a CBD-infused ice cream. the THC levels that differentiate industrial hemp from marijuana).

Law 40

Law Seed-To-Sale Hemp Recreational 40

The Cannigma

DECEMBER 22, 2021

We have autism and epilepsy. For example, when they open up the CBD-only market, products that will not contain THC, then they will probably find a solution there. We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Otherside Farms

JULY 25, 2019

CBD, or cannabidiol, is usually extracted from the hemp or comes from marijuana plants, but this does not produce a high like THC which is also found in marijuana plants. So far, trying to treat epilepsy with CBD has undergone a few clinical trials and we have more and more research on it.

Blood Pressure 12

Blood Pressure CBD Clinical Trials Epilepsy 12

The Cannigma

MARCH 12, 2021

And he’s looking at it and all these words are coming out, cannabinoids, THC, CBD, ratios, terpenes, and the customer realizes they have no idea what they’re doing. So, the strains that are very popular in the rec world are almost exclusively the high THC products. They’re using cannabis because they want to get high.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

AUGUST 12, 2019

Marijuana is high in the psychoactive compound THC, or delta-9 tetrahydrocannabinol, the compound in marijuana that causes a high. Although hemp does contain some cannabinoids, it has negligible amounts of THC. Keep in mind that to be considered “legal” CBD is required to have a THC level below.03%, Hemp is not marijuana.

CBD 40

CBD Terpenes Oil Tincture 40

Cannabis Law Report

DECEMBER 30, 2019

State lawmakers passed Assembly Bill 420 , which authorizes the University of California’s Center for Medicinal Cannabis Research to cultivate cannabis for clinical trials. Specifically, it expands the pool of patients eligible for cannabis therapy to include those with chronic pain, menstrual cramps, and epilepsy.

Legislation 59

Legislation Patients Access Banking 59